Determination of uric acid in human urine by ion chromatography with conductivity detector

A simple,fast,precise and eco-friendly analytical method for the determination of uric acid(UA) in human urine by ion chromatography(IC) was established.The sample pretreatment was not required,only needed centrifugation and filtration.The separation was carried out on a cation exchange column with 2.0 mmol/L nitric acid as mobile phase at the flow-rate 1.0 mL/min.A non-suppressed conductivity detector was used.The IC analysis time for one run was within 10 min under the optimized IC condition.The detection limits were 0.5μg/L(S/N = 3) for uric acid.The recovery was 100.1%while the relative standard deviation (RSD) was 1.8%from 10 measurements.     

HPLC法测定人尿中尿酸含量

建立了一种人体尿液中尿酸含量的高效液相色谱测定方法.采用ACE5 AQ亲水色谱柱,pH3.2的乙酸水溶液为流动相,检测波长280nm.尿酸含量在7.1～224.6μg/mL范围内线性关系良好,平均加样回收率为99.7%～100.5%,RSD小于1.4%.将该法用于健康人和肝硬化病人尿液样本的测定,两类样本中尿酸含量无显...     

Selective coulometric determination of uric acid in human urine using uricase

The coulometric determination of uric acid in human urine is done using porous carbon felt electrodes containing electrolyte. The diluted human urine is dropped on the carbon felt surface and uric acid is completely electrically oxidized in a few minutes. The coulombs consumed by interferences contained in human urine are determined by measuring the electrolytic oxidation of the same diluted human urine to which uricase is added. The current efficiencies of uric acid are nearly 100% (RSD < 1%). The results are in fairly good agreement with those obtained by sepectrophotometry.     

Disposable luminol copolymer-based biosensor for uric acid in urine

A new electrochemiluminescent (ECL) disposable biosensor for uric acid was manufactured by immobilization in a double-layer design of luminol as a copolymer with 3,3′,5,5′-tetramethylbenzidine (TMB) and the enzyme uricase in chitosan on gold screen-printed cells. The good mechanical and improved electroluminescent characteristics of the new copolymer poly(luminol–TMB) make it possible to determine uric acid by measuring the growing ECL emission with the analyte concentration. The combination of enzymatic selectivity with ECL sensitivity results in a disposable analytical device with a linear range for uric acid from 1.5 × 10⁻⁶ to 1.0 × 10⁻⁴ M, a limit of detection of 4.4 × 10⁻⁷ M and a precision of 13.1% (1.0 × 10⁻⁵ M, n = 10) as relative standard deviation. Satisfactory results were obtained for uric acid determination in 24 h-urine samples compared to a reference procedure. This uric acid biosensor can be used as a low-cost alternative to conventional methods.     

Determination of uric acid and creatinine in human urine using hydrophilic interaction chromatography

Uric acid is the end-product of purine metabolism and a major antioxidant in humans. The concentrations of uric acid in plasma and urine are associated with various diseases and routinely measured in clinical and biomedical laboratories using enzymatic conversion and colorimetric measurement. In this study a hydrophilic interaction chromatographic (HILIC) method was developed for simultaneous determination of uric acid and creatinine, a biomarker of urine dilution and renal function, in human urine. Urine samples were pretreated by dilution, protein precipitation, centrifugation and filtration. Uric acid and creatinine were separated from other components in urine samples and quantified using HILIC chromatography. A linear relationship between the ratio of the peak area of the standards to that of the internal standard and the concentration of the standards was obtained for both uric acid and creatinine with the square of correlation coefficients >0.999 for both analytes. The detection limits were 0.04 μg/mL for creatinine and 0.06 μg/mL for uric acid. The described HILIC method has proved to be simple, accurate, robust and reliable.     

Chemiluminescence assay for uric acid in human serum and urine using flow-injection with immobilized reagents technology

A novel chemiluminescence (CL) flow sensor for the determination of uric acid in human urine and serum has been developed by using controlled-reagent-release technology. The reagents involved in the chemiluminescence (CL) reaction, luminol and periodate, are immobilized on anion-exchange resin packed in a column. After injection of water, chemiluminescence generated by released luminol and periodate in alkaline media is inhibited in presence of uric acid. By measuring the decreased chemiluminescence (CL) intensity the uric acid is sensed. The decreased response is linear in the 5.0-500.0 ng mL(-1) range, with a detection limit of 1.8 ng mL(-1). The flow sensor showed remarkable operational stability and could be easily reused for over 80 h with sampling frequency of 100 h(-1). The proposed sensor was applied to the determination of uric acid in human urine and serum, and monitoring metabolic uric acid in human urine with RSD less than 3.0%.     

Microchip capillary electrophoresis with electrochemical detector for precolumn enzymatic analysis of glucose, creatinine, uric acid and ascorbic acid in urine and serum

An integrated multiple-enzymatic assay was performed on a (microchip capillary electrophoresis) μCE-EC chip capable of precise intake of sample or reagents in nanoliters. Incorporating multiple-enzyme assay into the μCE chip is relatively new—rendering simultaneous analysis of creatinine and uric acid a snap.Added to the list of merits in this study are the enhanced sensitivity down to 1 μM and a broader spectrum of analytes—inclusive of glucose for the long-time sufferers of diabetes. The performance was orchestrated to attain the claimed level: employing the end-channel electrode mode to tame the noises and the precolumn enzymatic reaction to stabilize the baseline. The 10 μm embedded Pt electrode, deposited at the end of the 30 μm wide separation channel, benefited chip fabrication besides noise reduction. The optimized conditions were 20 mM phosphate buffer (pH 7.5), +1.5 kV separation voltage and +1.0 V detection potential (versus Ag/AgCl). The migration time was repeatable within the deviation of 0.5% R.S.D. (n=7), but the peak currents ranged from 1.5 to 2.2% R.S.D. The detection limits (S/N=3) ranged from 0.71 μM for ascorbic acid to 10 μM for glucose. The calibration curve was linear from 10 to 800 μM (R²>0.995). Glucose, creatinine, uric acid and ascorbic acid as model analytes, in pure form or in serum and urine samples, were tested to verify its feasibility.     

聚茜素黄R膜修饰电极对尿酸电催化及对人尿中尿酸的检测

用电聚合的方法制备了聚茜素黄R膜修饰的玻碳电极,研究了尿酸在该电极上的电化学行为。结果表明,该修饰电极对尿酸的氧化具有良好的电催化能力。示差脉冲伏安法测定尿酸的氧化峰电流与其浓度在1.0×10-6～1.0×10-4mol/L范围内呈现良好的线性范围,检测限为8.6×10-7 mol/L(S/N=3)。本方法用于人尿液中尿酸含量的测定,结果令人满意。     

Layer-by-layer sensor architecture of polymers and nanoparticles for electrochemical detection of uric acid in human urine samples

Excessive uric acid levels in the human body (hyperuricemia) are the main causes of kidney stones and diabetes. In this study, a layer-by-layer arrangement of polymers and nanocomposites is used as a new electrode sensing material for rapid and direct electrochemical determination of uric acid (UA). The electrode surface architecture was constructed by the incorporation of poly (amidoamine) dendrimer with 0.5 generation (poly (amidoamine) [PAMAM] [D-G0.5]) of multiwalled carbon nanotube-silver nanoparticles (MWCNT-AgNP) and a poly (neutral-red) (poly [NR]) polymer. The PAMAM (D-G0.5)/MWCNT-AgNP/poly (NR)-coated electrode has a good electrocatalytic activity for the determination of UA using cyclic voltammetry and showed remarkable enhancement in current response at a low-oxidation potential (0.3 V). Under optimal conditions, the developed electrochemical sensor showed an excellent and wide linear range for the determination of UA (i.e. 0.016 μM–2500 μM), and the limit of detection was found to be 0.005 μM. The modified sensor system demonstrated excellent sensitivity and selectivity toward the detection of UA in the presence of interfering substances, which are commonly found in urine and human fluid samples. Furthermore, the developed sensor has represented both reproducibility and excellent stability for the UA determination in real samples (human urine).     

Silver nanoparticles plasmon resonance-based method for the determination of uric acid in human plasma and urine samples

We have developed a simple and sensitive colorimetric procedure for the quantification of trace amounts of uric acid. It is based on the finding that uric acid in a medium containing ammonia and sodium hydroxide at 65?°C can reduce silver ions to form yellow silver nanoparticles (Ag NPs). These are stabilized in solution by using poly(vinyl alcohol) as a capping agent. The yellow color of the solution that results from the localized surface plasmon resonance of Ag NPs can be observed by the bare eye. The absorbance at 415?nm is proportional to the concentration of uric acid which therefore can be determined quantitatively. The calibration curve is linear in the concentration range from 10 to 200?nM, with a limit of detection of 3.3?nM. The method was successfully applied to the determination of uric acid in human plasma and urine samples.

Determination of uric acid in human urine by capillary zone electrophoresis with indirect laser-induced fluorescence detection

A CZE with indirect LIF detection method was used for the determination of uric acid (UA) in human urine. UA and its coexisting analytes (i.e. hypoxanthine, xanthine and ascorbic acid) could be well separated within 4.5?min at a voltage of 25?kV with 25°C cartridge temperature in a running buffer composed of 5?mM sodium borate, 10% methanol (v/v) and 0.3?μM fluorescein sodium (apparent pH of the final mixed hydro-organic solution of sodium borate, methanol and fluorescein is 9.5). Under the optimum condition, the method has good linearity relationships (correlation coefficients: 0.9973-0.9987) with ranges of 25-500, 25-350, 25-250 and 25-300?μg/mL for hypoxanthine, ascorbic acid, xanthine and UA, respectively. The detection limits for the analytes were in the range of 0.29-0.90?μg/mL. The intra-day RSD values for migration times and peak areas were less than 0.43 and 3.27%, respectively. This method was applied to the quantitation of UA in human urine with recoveries in the range of 93.1-107.3%.     

Simultaneous determination of creatinine and uric acid in human plasma and urine by micellar electrokinetic chromatography

High performance capillary electrophoresis using a buffer solution containing micelles of ionic surfactant (e.g. sodium dodecyl sulfate), called micellar electrokinetic chromatography, has been applied to the separation and simultaneous determination of creatinine and uric acid in human plasma and urine. The sample was introduced into the capillary by siphoning an appropriate volume of untreated plasma or urine spiked with an internal standard (antipyrine). Creatinine, uric acid, and antipyrine were separated mutually, and from other endogeneous components within 18 min. The calibration plots showed good linearity (correlation coefficient > 0.999) over the concentration range needed for clinical analysis. Standard addition tests indicated that the recoveries of creatinine and uric acid from urine samples ranged, respectively, from 97 % to 106 % and 97.4 % to 108 % with a coefficient of variation (C.V.) of 3.3 % (n = 5), and that those from plasma samples ranged, respectively, from 100 % to 112 % and 101 % to 107 % with a C.V. of 4.7 % (n = 5). The results were in agreement with those obtained by conventional methods.     

基于纳米结构BDD电极的人体尿酸检测

利用纳米结构硼掺杂金刚石(nBDD)电极的优点对人体尿液中的UA含量进行检测,并与常规玻碳(GC)电极做了比较。检测不同尿样的结果可知,nBDD电极检测的回收率为95.3%～98.4%,GC电极79.6%～87.1%;检测同一尿样的重复性实验得出,nBDD电极上峰电流的相对标准偏差(RSD)为8.0%,GC电极上峰电流的RSD为39%。     

A biosensor based on urate oxidase-peroxidase coupled enzyme system for uric acid determination in urine

A new amperometric biosensor based on urate oxidase-peroxidase coupled enzyme system for the specific and selective determination of uric acid in urine was developed. Commercially available urate oxidase and peroxidase were immobilized with gelatin by using glutaraldehyde and fixed on a pretreated teflon membrane. The method is based on generation of H₂O₂ from urine uric acid by urate oxidase and its consuming by peroxidase and then measurement of the decreasing of dissolved oxygen concentration by the biosensor. The biosensor response depends linearly on uric acid concentration between 0.1 and 0.5 μM. In the optimization studies of the biosensor, phosphate buffer (pH 7.5; 50 mM) and 35 °C were obtained as the optimum working conditions. In addition, the most suitable enzyme activities were found as 64.9×10⁻³ U cm⁻² for urate oxidase and 512.7 U cm⁻² for peroxidase. And also some characteristic studies of the biosensor such as reproducibility, substrate specificity and storage stability were carried out.     

顺序注射在线稀释测定人体液中尿酸

基于酸性条件下甲醛对尿酸-KMnO4发光反应的增敏作用,建立了在线稀释顺序注射化学发光联用技术测定人体液中尿酸的新方法。在选定的实验条件下的7个浓度梯度范围内,尿酸浓度在5.0×10-6mol/L~1.0×10-3mol/L范围内与发光强度呈良好线性关系,相关系数0.9942~0.9998,RSD在2.0%~3.5%之间,回收率为98.0%~103.0%。每小时可分析80个样品,在线稀释测定结果与手工稀释法一致。     

A flow-based procedure with solenoid micro-pumps for the spectrophotometric determination of uric acid in urine

The determination of uric acid in urine shows clinical importance, once it can be related to human organism dysfunctions, such as gout. An analytical procedure employing a multicommuted flow system was developed for the determination of uric acid in urine samples. Cu(II) ions are reduced by uric acid to Cu(I) that can be quantified by spectrophotometry in the presence of 2,2′-biquinoline 4,4′-dicarboxylic acid (BCA). The analytical response was linear between 10 and 100 μmol L^− 1 uric acid with a detection limit of 3.0 μmol L^− 1 (99.7% confidence level). Coefficient of variation of 1.2% and sampling rate of 150 determinations per hour were achieved. Per determination, 32 μg of CuSO₄ and 200 μg of BCA were consumed, generating 2.0 mL of waste. Recoveries from 91 to 112% were estimated and the results for 7 urine samples agreed with those obtained by the commercially available enzymatic kit for determination of uric acid. The procedure required 100-fold dilution of urine samples, minimizing sample consumption and interfering effects. In order to avoid the manual dilution step, on-line sample dilution was achieved by a simple system reconfiguration attaining a sampling rate of 95 h^− 1.     

多羟基化合物化学发光分析新体系的研究: 尿液中尿酸的测定

本文首次提出使用luminol-K7[Cu(IO6)2]-KOH化学发光体系, 结合流动注射技术进行多羟基化合物的测定。方法基于多羟基化合物能增强luminol与K7[Cu(IO6)2]反应产生的化学发光, 且浓度与增强作用的大小呈线性关系。利用该法进行尿酸的测定, 发现尿酸在2×10^-^8~1×10^-^6g/mL浓度范围内与化学发光强度呈线性关系, 检出限为7.2×10^-^9g/mL, 相对标准偏差为2.04%。     

Spectrofluorimetric method for the determination of uric acid in human serum

A new spectrofluorimetric method is described for the determination of uric acid (UA), that can remarkably reduce the fluorescence intensity of the enoxacin (ENX)-terbium ion (Tb³⁺) complex at 545 nm. The reduced fluorescence intensity of Tb³⁺ ion at pH 5.7 is proportional to the concentration of UA. Optimum conditions for the determination of UA have been investigated. The linear range and detection limit for the determination of UA are 6.0 × 10^?7–3.0 × 10^?5 M and 1 × 10^?7 M, respectively. The relative standard deviation (RSD) was 0.4% for 6 × 10^?6 M UA (n = 11). The method is simple, practical and relatively free of interferences. It has been successfully applied to assess UA in serum at the level of 3 × 10^?4 M with an RSD of 5–7% (n = 3). The results were evaluated by comparison with a common clinical spectrophotometric method using phosphotungstic acid as developer.     

Surface modification of poly(dimethylsiloxane) microfluidic devices and its application in simultaneous analysis of uric acid and ascorbic acid in human urine

A novel and simple method based on layer-by-layer (LBL) technique has been developed for the modification of the channel in PDMS electrophoresis microchip to create a hydrophilic surface with a stable EOF. The functional surface was obtained by sequentially immobilizing chitosan and deoxyribonucleic acid (DNA) onto the microfluidic channel surface using the LBL assembly technique. Compared to the native PDMS microchips, the contact angle of the chitosan-DNA modified PDMS microchips decreased and the EOF increased. Experimental conditions were optimized in detail. The chitosan-DNA modified PDMS microchips exhibited good reproducibility and long-term stability. Separation of uric acid (UA) and ascorbic acid (AA) performed on the modified PDMS microchip generated 43,450 and 46,790 N/m theoretical plates compared with 4048 and 19,847 N/m with the native PDMS microchip. In addition, this method has been successfully applied to real human urine samples, without SPE, with recoveries of 97-105% for UA and AA.